This announcement is a separate document:
ペルセウスプロテオミクス：PPMX-T003：真性多血症（PV）第I相試験終了のお知らせ
Perseus Proteomics: Announcements of individual stocks: PPMX-T003: Announcement of the end of Phase I trial for polycythemia vera (PV).
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.